Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Does natalizumab therapy worsen neuromyelitis optica?
Cortical Pathology in RRMS: Taking a Cue from Four Sisters.
Clinical designs of recent robot rehabilitation trials.
Role of metabotropic glutamate receptor 5 signaling and homer in oxygen glucose deprivation-mediated astrocyte apoptosis.
Effects of Ferrofluid and Phytoalexin Spirobrassinin on Thioflavin-T-Based Fluorescence in Cerebrospinal Fluid of the Elderly and Multiple Sclerosis Patients.
[Recent prognosis on etiology and pathophysiology of multiple sclerosis].
Enigmatic GPCR Finds a Stimulating Drug.
A validated regulatory network for Th17 cell specification.
Optical Coherence Tomography for the Radiologist.
MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.
Acute Disseminated Encephalomyelitis Associated With Acute Toxoplasma gondii Infection.
[The activation of the type I interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data.]
Balanced mTORC1 Activity in Oligodendrocytes Is Required for Accurate CNS Myelination.
Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients.
Decoding Signaling and Function of the Orphan G Protein-Coupled Receptor GPR17 with a Small-Molecule Agonist.
Smokers run increased risk of developing anti-natalizumab antibodies.
Use of Rasch analysis to refine a patient-reported questionnaire on satisfaction with communication of the multiple sclerosis diagnosis.
The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis.
Movement disorders in multiple sclerosis.
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
Poster abstracts from the third international symposium on gait and balance in multiple sclerosis: selecting the right measures.
The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components.
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis.
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration.
Pages
« first
‹ previous
…
273
274
275
276
277
278
279
280
281
…
next ›
last »